Table 2.
Mean baseline and fourth year CD4+ and CD8+ cell count of pre-ART subjects
| Cells/μl | Year | HIV/HCV co-infected (G4) (n = 9) Mean ± SD | HIV mono-infected (G3) (n = 9) Mean ± SD | p value |
|---|---|---|---|---|
| CD4+ |
1st year |
303 ± 73 |
435 ± 52 |
P < 0.003 |
| 4th year |
211 ± 163 |
314 ± 27 |
P < 0.004 |
|
| CD8+ |
1st year |
1612 ± 380 |
1676 ± 343 |
N/S |
| 4th year | 772 ± 552 | 1092 ± 177 | P < 0.002 |
(Number of patients in parenthesis), N/S- not significant.
Key: G = Group, HAART = highly active antiretroviral therapy, ART = Antiretroviral treatment, μl = microliter, CD = Cluster designation/differentiation, SD = standard deviation.